Paratek Pharmaceuticals, Inc. (PRTK) Stock Analysis
DELISTED 2023
What happened to Paratek Pharmaceuticals, Inc. (PRTK) stock?
Paratek Pharmaceuticals, Inc. (PRTK) no longer trades on public markets. It was delisted in September 2023. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- September 2023
- Last recorded price (historical):
- $2.23 (last quote on record before the September 2023 delisting; historical, not a current quote)
Market cap $128M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Paratek Pharmaceuticals, Inc. (PRTK). Paratek Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for life-threatening diseases and public health threats.
Last analyzed: May 10, 2026Paratek Pharmaceuticals, Inc. (PRTK) Healthcare & Pipeline Overview
More about this archive record
Can I still buy PRTK shares?
No. PRTK stopped trading on public markets in September 2023, so the shares are not available through a broker. Anything you see quoted for PRTK elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before PRTK stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Paratek Pharmaceuticals, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.